Navigation Links
UCB Presents Long-Term CImzia Data in Crohn's Disease

Cimzia Maintained Long-term Response at Stable Doses, According to New Data Presented at Digestive Disease Week (DDW)

ATLANTA, May 22, 2007 /PRNewswire/ -- UCB announced today that new data presented at Digestive Disease Week 2007 (DDW) demonstrated long-term response and remission in Crohn's disease patients treated with Cimzia (certolizumab pegol), the only Fc-free PEGylated, Fab' fragment anti-TNF.

The study, called PRECiSE 3 (P3), is a long-term open label continuation of the Phase III PRECiSE Program for CIMZIA(TM). Some of the study results presented at DDW are an interim analysis of a patient subgroup that responded continuously to CIMZIA(TM) during an 18-month period. These patients completed the PRECiSE 1 (P1) or PRECiSE 2 (P2) trials, enrolling in P3 at week 26. At week 80, the study showed that more than 85 percent of the patient subgroup who continuously received CIMZIA(TM) 400 mg subcutaneously every four weeks maintained clinical response, with nearly 74 percent of these patients achieving remission. (1) The extension study used the Harvey-Bradshaw Index (HBI)(a) to assess clinical response (defined as a reduction in HBI score of at least three points) and remission (HBI score less than or equal to four points).

Importantly, results reported from P3 indicated that CIMZIA(TM) was well- tolerated throughout the study. The percentage of patients experiencing injection-site reactions and injection-site pain was low (<2%, <1% respectively). (3)

"These study results show robust rates of clinical response and remission during an 18-month period in patients with Crohn's disease," said Stephen Hanauer, M.D., Professor of Medicine and Clinical Pharmacology Chief, Section of Gastroenterology and Nutrition, University of Chicago, and study co-author. "Also, CIMZIA(TM) dosing did not need to be increased over the course of the study."

"These results fortify UCB's commitment to obtai
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCB Presents Long Term CImzia Data Crohn Disease
(Date:3/6/2015)... CHESTNUT RIDGE, N.Y. , March 6, 2015 ... it will host a conference call on Friday, ... review its results of operations for the fourth ... Par is privately held and currently makes certain ... filings with the Securities and Exchange Commission and ...
(Date:3/6/2015)... Del. , March 6, 2015 ... and Trademark Office,s publication of U.S. Patent Application ... Disorder."  The ,249 Patent Application features claimed methods of ... be used to treat Binge Eating Disorder (,BED,)," ... material," or "flyer or an advertisement," as well ...
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3
... Mich., June 15, 2011 Perrigo Company (Nasdaq: ... Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories ... Teva was the first applicant to file a complete ANDA ... be launching the product with 180 days of generic exclusivity. ...
... BRANFORD, Connecticut, June 15, 2011 , ... has killed dozens and,hospitalized thousands across Europe has been ... to generate the,"most accurate and detailed genetic analysis to ... ] ,The sequencing was performed by scientists at the ...
Cached Medicine Technology:Perrigo Announces Launch of the Generic Version of Nasacort® AQ 2Perrigo Announces Launch of the Generic Version of Nasacort® AQ 3Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 2Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 3
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
(Date:3/6/2015)... Utilizing the latest in nutritional science ... ideal weight has enabled Diet Doc to add powerful ... impressive collection of fat loss enhancement medications. And now, ... and savings to help people throughout the country begin ... is especially appealing to new clients because they can ...
(Date:3/6/2015)... Toronto, ON (PRWEB) March 06, 2015 ... with the Canadian Celiac Association, is pleased to ... founded by Dufflet Rosenberg, has expanded their product ... and they are as scrumptious and as satisfying ... is hand-crafted from scratch, and never contains hydrogenated ...
(Date:3/6/2015)... 2015 Los Angeles cosmetic dentist , ... Zoom whitening. Zoom is a special type of teeth whitening ... other teeth whitening treatments, Zoom does its job in about ... For a limited time, Dr. Ghasri is offering Zoom for ... price of $650 and allows patients to try out this ...
(Date:3/6/2015)... Oak Brook, IL (PRWEB) March 06, 2015 ... and 15-time Boston Marathon qualifier, developed the Fluid ... injured just weeks before the Chicago marathon. She hit ... atmosphere of a group run, and a maximum-resistance, deep ... but created a unique no-impact, deep water running workout ...
Breaking Medicine News(10 mins):Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 3Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 4Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3
... colorectal cancer who require the surgical removal of ... procedure may decrease the time they spend// in ... the benefits of laparoscopic surgery and open surgery. ... are currently recruiting patients for a clinical research ...
... than 65 has been the victim of physical, sexual or ... intimate partner// , according to a study done in two ... surveyed had suffered violence in the past five years, and ... violence is not a problem only for younger women,” said ...
... fraternal twin, she was born without four ribs on her ... scoliosis. With an under-developed chest cavity, Ariana faced severe lung ... knowing that we would have a long and difficult road ... if she would be able to tie her shoes, ride ...
... Dance has been found to be more appropriate to de-stress oneself, ... tried going to the gym to tone up my body but ... got bored of that as well. Finally, I put on my ... doctor at the Apollo Hospital here. ,Learning various dance ...
... is significantly worse than that of other vulnerable groups, reveals ... ,It is not known how many Gypsies and Travellers ... around 300,000. ,The researchers assessed the health of ... origin in five locations across England (Sheffield, Leicester, Norfolk, London, ...
... (ADA) has warned that the diabetes threat is greater than ... 2 diabetes among middle aged Americans has doubled over the ... the ADA said. ,An estimated two-thirds of adult ... can now expect many more people to succumb to this ...
Cached Medicine News:Health News:New Surgical Technique Decreases Colorectal OR Time 2Health News:Study Finds Many Older Women Also Victims of Partner Violence 2Health News:New Device Offers Hope to Children With Chest, Spinal Deformities 2Health News:Dance to De-stress 2Health News:Diabetes Threat Greater Than Feared 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: